Financial News
Cardiol Therapeutics (NQ: CRDL )
1.545
-0.015
(-0.96%)
Streaming Delayed Price
Updated: 2:44 PM EST, Nov 21, 2024
Add to My Watchlist
Press Releases about Cardiol Therapeutics
“Emerging Innovators Transforming Global Markets: IPA, CRDL, KXIN, GNS, PRSO in Sectors”
November 13, 2024
Via AB Newswire
Topics
Electric Vehicles
“Trump Media (NASDAQ: DJT) Surges on Election Day as SmallCap Stocks CRDL, ALBT, ZVSA, PRSO Emerge”
November 05, 2024
Via AB Newswire
Topics
Government
Exposures
Political
“Top Biotech Opportunities: RVNC, HCTI, GLUE, PRSO, CRDL, Showing Promising Developments”
October 28, 2024
Via AB Newswire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Healthcare and Biotech Stocks to Watch: MODD, CRDL, DBVT, VRAX
October 23, 2024
Via AB Newswire
Topics
Intellectual Property
Exposures
Intellectual Property
Via TheNewswire.com
Exposures
Product Safety
Via Newsfile
Cardiol Therapeutics Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment of Pericarditis
February 15, 2024
Via Newsfile
Exposures
Product Safety
Cardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart Diseases
October 13, 2023
Via Get News
Topics
Death
Exposures
Death
Cardiol Therapeutics (NASDAQ: CRDL)
Advancements in Therapies for Inflammatory Heart Diseases
October 13, 2023
Via TheNewswire.com
Topics
Death
Exposures
Death
Via Newsfile
Via Newsfile
Sidoti's Micro-Cap Virtual May Conference
May 09, 2023
Via ACCESSWIRE
Air Pollution is a Global Heart and Lung Health Concern
July 18, 2022
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.